Corrigendum to: Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders.

The error was noted after the publication of the article titled 'Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders'', published in Recent Patents on Nanotechnology, 2025, 1, 17-34 [1], that a part of the text was inadvertently omitted. The missing text has now been included as: The original article can be found online at: https://www.eurekaselect.com/article/132973 We regret the error and apologize to readers. Details of the error and a correction are provided here. Original: Nanotheranostic However, we may encounter more significant difficulties with their in vivo studies by invalidating their safety and efficacy before clinical applications. Corrected: Nanotheranostic systems are being utilised in addition to imaging and treatment to track pharmacokinetics, the dispersion of particles in the tissue, and drug accumulation at the target site. Using this cutting-edge technology, a thorough understanding of the pathophysiology of neurological illnesses has been attained. The manufacture and physiochemical characterisation of nanotheranostics has been the main foci of notable in vitro studies in the current situation. However, we may encounter more significant difficulties with their in vivo studies by invalidating their safety and efficacy before clinical applications.